Literature DB >> 2346524

Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation.

P Larsson1, S Kleinau, R Holmdahl, L Klareskog.   

Abstract

Arthritis was induced in Lewis and DA rat strains after immunization with native homologous type II collagen (CII). Differences were noted in the clinical signs of arthritis in the 2 rat strains, which were immunized with the same arthritogenic preparation of CII. DA rats showed disease onset characterized by symmetric involvement of the interphalangeal joints of the hind feet. Lewis rats showed disease onset characterized by involvement of only the ankle or knee joints. Moreover, the arthritis tended to be chronic (i.e., persistent and variable redness and swelling seen in interphalangeal joints) in DA rats, but not in Lewis rats. Analysis of the delayed-type hypersensitivity reaction to CII and anti-CII autoantibody production demonstrated the presence of T cell, as well as B cell, reactivity to rat CII in both strains of rat. A spontaneous T cell reactivity to CII, as measured by rat CII-induced ear swelling, was observed in nonimmunized DA rats, but not in nonimmunized Lewis rats. The demonstration that clinical features of arthritis induced with identical arthritogenic stimuli are different depending on the genetic background of the affected animal may be relevant in understanding the heterogeneity of the clinical features of human inflammatory joint disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346524     DOI: 10.1002/art.1780330512

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  34 in total

1.  Antigen inhibition of collagen-induced arthritis is associated with up-regulation of IL-4 mRNA and induction of Ox40 on T cells in draining lymph nodes.

Authors:  L Mattsson; K Lundberg; E Mussener; A Jansson; H Erlandsson Harris; P Larsson
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

2.  The effects of flurbiprofen on the passive transfer of adjuvant-induced arthritis.

Authors:  G W Cannon; D S Harper
Journal:  Agents Actions       Date:  1992-01

3.  Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease.

Authors:  R Holmdahl; T J Goldschmidt; S Kleinau; C Kvick; R Jonsson
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

4.  Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats.

Authors:  K kerlund; H Erlandsson Harris; K J Tracey; H Wang; T Fehniger; L Klareskog; J Andersson; U Andersson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis : a therapeutic study using a macrophage-deactivating compound.

Authors:  K Palmblad; H Erlandsson-Harris; K J Tracey; U Andersson
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  Pemetrexed ameliorates experimental arthritis in rats.

Authors:  Ahmet Karatas; Suleyman Serdar Koca; Metin Ozgen; Adile Ferda Dagli; Fazilet Erman; Nuran Sahin; Kazim Sahin; Ahmet Isik
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

7.  Identification of rat susceptibility loci for adjuvant-oil-induced arthritis.

Authors:  J C Lorentzen; A Glaser; L Jacobsson; J Galli; H Fakhrai-rad; L Klareskog; H Luthman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 8.  What can we learn about rheumatoid arthritis from animal models?

Authors:  L Klareskog
Journal:  Springer Semin Immunopathol       Date:  1989

9.  A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia.

Authors:  P Larsson; L Mattsson; L Klareskog; C Johnsson
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Prevention of experimental autoimmune encephalomyelitis in DA rats by grafting primary skin fibroblasts engineered to express transforming growth factor-beta1.

Authors:  T Zargarova; O Kulakova; V Prassolov; T Zharmukhamedova; V Tsyganova; V Turobov; D Ivanov; M Parfenov; M Sudomoina; Y Chernajovsky; O Favorova
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.